Moovcare® is the first digital therapeutics reimbursed in France!
Moovcare® defines a new reality in cancer follow-up, by empowering patients with symptoms management and providing the care givers a reliable digital tool to monitor their patients.
Symptoms management is essential from a psychological and physical point of view when considering treatment option for cancer patients.

Moovcare® is the first digital therapeutics received a favorable opinion on reimbursement with an ASA III.